The hedge fund’s shares of LifePoint are valued at $1.06 million. LifePoint makes up about 0.04 percent of Ronald Blue’s portfolio, according to Market Digest.
LifePoint reported revenue of $1.6 billion in the second quarter, up 25.3 percent from $1.3 billion in the same period of the year prior. After accounting for a sharp increase in expenses, LifePoint ended the second quarter with net income of $20.1 million, down 59.6 percent from $49.8 million in the same quarter of the year prior.
More articles on healthcare finance:
AHA asks judge to require HHS to resolve Medicare appeals backlog
This week’s 5 must-reads for hospital CFOs
CFO roundtable: 3 finance leaders on clinical staffing, retention issues
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
